Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabis for Chronic Pain and Palliative Care
NCT02683018Phase 1Withdrawn
- Sponsor
- New York State Psychiatric Institute
- Primary completion
- Oct 2021
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial in chronic pain comparing Smoked Cannabis High CBD/low THC with Smoked Placebo Cannabis Low CBD/low THC (2 arms). Primary endpoints: Change in pain ratings using the McGill Pain Questionnaire at 4 weeks, Change in sickness-related impairment using the Sickness Impact Profile at 4 weeks and 2 more. Status: withdrawn.
02
Drugs
cannabidiol
03
Conditions
chronic pain
Beyond the preview
Go deeper on NCT02683018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02683018.